This article was originally published in The Gray Sheet
Executive SummarySelf-administered TCI Ovulation Tester receives FDA over-the-counter clearance for detecting the most fertile days of a woman's menstrual cycle by the direct visualization of characteristic peri-ovulatory ferning patterns seen in dried saliva. In clinical trials, saliva ferning on a glass slide could be identified 93% of the time by untrained women using the device's mini-microscope. The test, which produces results in 10 minutes, demonstrated substantial equivalence to Quidel's urine sample-based Conceive ovulation predictor...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.